Intrapulmonary Pharmacokinetics of Cefepime and Enmetazobactam in Healthy Volunteers: Towards New Treatments for Nosocomial Pneumonia.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
16 12 2020
Historique:
received: 10 07 2020
accepted: 13 10 2020
pubmed: 21 10 2020
medline: 22 6 2021
entrez: 20 10 2020
Statut: epublish

Résumé

Cefepime-enmetazobactam is a novel β-lactam-β-lactamase inhibitor combination with broad-spectrum antimicrobial activity against a range of multidrug-resistant

Identifiants

pubmed: 33077666
pii: AAC.01468-20
doi: 10.1128/AAC.01468-20
pmc: PMC7927813
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Azabicyclo Compounds 0
Cephalosporins 0
Triazoles 0
Cefepime 807PW4VQE3
enmetazobactam 80VUN7L00C

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Curr Opin Pharmacol. 2017 Oct;36:114-123
pubmed: 29096171
Antimicrob Agents Chemother. 2015 May;59(5):2688-94
pubmed: 25712356
Crit Care Med. 2003 Aug;31(8):2102-6
pubmed: 12973166
Ther Drug Monit. 2012 Aug;34(4):467-76
pubmed: 22722776
Intensive Care Med. 2004 May;30(5):989-91
pubmed: 14985960
Antimicrob Agents Chemother. 1985 Feb;27(2):207-16
pubmed: 3885849
Expert Opin Pharmacother. 2016;17(7):953-67
pubmed: 26891857
Antibiotics (Basel). 2020 Feb 05;9(2):
pubmed: 32033322
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32253209
JAMA. 2018 Sep 11;320(10):984-994
pubmed: 30208454
Antimicrob Agents Chemother. 1987 Jan;31(1):55-9
pubmed: 3566239
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32253212
J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Feb 15;917-918:24-9
pubmed: 23353811
Lancet Infect Dis. 2019 Dec;19(12):1299-1311
pubmed: 31563344
J Infect Dis. 2005 Jun 15;191(12):2149-52
pubmed: 15898002
Antimicrob Agents Chemother. 2019 Jun 24;63(7):
pubmed: 30988152
Eur J Clin Pharmacol. 2020 Mar;76(3):349-361
pubmed: 31836928
J Antimicrob Chemother. 2018 May 1;73(5):1340-1347
pubmed: 29385448
Antimicrob Agents Chemother. 2015 Nov 02;60(1):368-75
pubmed: 26525790
Antimicrob Agents Chemother. 2016 Nov 21;60(12):7272-7279
pubmed: 27671063
Antimicrob Agents Chemother. 2019 Apr 25;63(5):
pubmed: 30858223

Auteurs

Shampa Das (S)

Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom.

Richard Fitzgerald (R)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.

Asad Ullah (A)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.

Marcin Bula (M)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.

Andrea M Collins (AM)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Elena Mitsi (E)

Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Jesus Reine (J)

Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Helen Hill (H)

Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Jamie Rylance (J)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.
Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Daniela M Ferreira (DM)

Liverpool School of Tropical Medicine, Liverpool Health Partners, Liverpool, United Kingdom.

Karen Tripp (K)

Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.

Andrea Bertasini (A)

Aptuit (Verona) Srl, an Evotec Company, Verona, Italy.

Samantha Franzoni (S)

Aptuit (Verona) Srl, an Evotec Company, Verona, Italy.

Mameli Massimiliano (M)

Aptuit (Verona) Srl, an Evotec Company, Verona, Italy.

Omar Lahlou (O)

Allecra Therapeutics SAS, St-Louis, France.

Paola Motta (P)

Allecra Therapeutics SAS, St-Louis, France.

Philip Barth (P)

Allecra Therapeutics SAS, St-Louis, France.

Patrick Velicitat (P)

Allecra Therapeutics SAS, St-Louis, France.

Philipp Knechtle (P)

Allecra Therapeutics SAS, St-Louis, France.

William Hope (W)

Antimicrobial Pharmacodynamics and Therapeutics, University of Liverpool, Liverpool Health Partners, Liverpool, United Kingdom william.hope@liverpool.ac.uk.
Liverpool University Hospital Foundation Trust, Liverpool Health Partners, Liverpool, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH